45 employees
IZumi Bio, a biotechnology company, employs cellular reprograming for the development of stem cell-based therapeutics.
2007
$20M
from 2 investors over 2 rounds
Izumi raised $20M on April 14, 2009
Investors: Kleiner Perkins and HCP Ltd